Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin
The British Journal of Psychiatry March 30, 2026 Katharine A. Smith, Edward Harcourt, Andrea Cipriani 1 citation
Psychedelics like psilocybin are being explored as a new treatment for depression, but their use requires psychological support alongside the drug. There is debate about the exact role of this support and who should deliver it, which affects how these treatments could be implemented in public health services like the National Health Service. The authors outline a model for delivering psychological support in publicly funded settings and call for further research to identify the essential elements of support. They emphasize that implementation must be based on high-quality evidence and ensure equitable access for all patients, not just those who can pay.